Methamphetamine (METH) is a powerful central nervous system stimulant which elevates
mood, alertness, energy levels and concentration in the short-term. However, chronic use …

Methamphetamine (METH) is a potent psychostimulant that increases extracellular
monoamines, such as dopamine and norepinephrine, and affects multiple tissue and cell …

Methamphetamine (METH) is a highly addictive drug abused by millions of users worldwide,
thus becoming a global health concern with limited management options. The inefficiency of …

Methamphetamine (METH) is an addictive and illegal psychostimulant drug that can cause
multiple organ dysfunction, especially in the central nervous system (CNS). Gut microbiota …

There are only a few studies reporting on the immunological profiles of methamphetamine
(MA) use, MA dependency, or MA-induced psychosis (MAP). This study measured M1 …

Substance use disorders (SUDs) represent a significant public health crisis. Worldwide,
5.4% of the global disease burden is attributed to SUDs and alcohol use, and many more …

Clinical and preclinical studies have indicated that chronic methamphetamine (MA) use is
associated with extensive neurodegeneration, psychosis, and cognitive impairment …

Objective Funding to address the current opioid epidemic has focused on treatment of opioid
use disorder (OUD); however, rates of other substance use disorders (SUDs) remain high …

Methamphetamine (METH) abuse is a major public health issue around the world, yet there
are currently no effective pharmacotherapies for the treatment of METH addiction. METH is a …

Methamphetamine (MA) use is a major public health problem in the United States,
especially among people living with HIV (PLWH). Many MA-induced neurotoxic effects are …